PCRX Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance MSGS Q1 2026 Earnings EPS Falls Well Below Estimates as Stock Holds Steady YDKG Q4 2012 Earnings EPS Misses Estimates Amidst Uncertain Operating Environment SU Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Strength TNXP Q1 2026 Earnings WiderThanExpected Loss Amid Continued Pipeline Development Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs